PNC Financial Services Group’s Arcutis Biotherapeutics ARQT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$415K	Buy	17,597 +4,000	+29%	+$102K	﹤0.01%	1816
2025 Q4	$395K	Buy	13,597 +4,991	+58%	+$128K	﹤0.01%	1840
2025 Q3	$162K	Sell	8,606 -222	-3%	-$3.5K	﹤0.01%	2439
2025 Q2	$124K	Buy	8,828 +820	+10%	+$11.5K	﹤0.01%	2558
2025 Q1	$125K	Sell	8,008 -263	-3%	-$3.71K	﹤0.01%	2515
2024 Q4	$115K	Sell	8,271 -1,648	-17%	-$18.1K	﹤0.01%	2597
2024 Q3	$92.2K	Buy	9,919 +188	+2%	+$1.85K	﹤0.01%	2714
2024 Q2	$90.5K	Sell	9,731 -33	-0.3%	-$298	﹤0.01%	2694
2024 Q1	$96.8K	Buy	9,764 +241	+3%	+$1.8K	﹤0.01%	2633
2023 Q4	$30.8K	Buy	9,523 +539	+6%	+$1.47K	﹤0.01%	3210
2023 Q3	$47.7K	Sell	8,984 -831	-8%	-$7.07K	﹤0.01%	2984
2023 Q2	$93.5K	Buy	9,815 +1,598	+19%	+$17.7K	﹤0.01%	2682
2023 Q1	$90.4K	Sell	8,217 -5,763	-41%	-$83.4K	﹤0.01%	2626
2022 Q4	$207K	Buy	13,980 +4,415	+46%	+$77.1K	﹤0.01%	2102
2022 Q3	$183K	Buy	9,565 +6,917	+261%	+$157K	﹤0.01%	2146
2022 Q2	$56K	Buy	+2,648	New	+$54.3K	﹤0.01%	2916
2021 Q4	–	Sell	-1,500	Closed	-$36K	–	4436
2021 Q3	$36K	Hold	1,500	–	–	﹤0.01%	3246
2021 Q2	$40K	Buy	+1,500	New	+$42.3K	﹤0.01%	3181